These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 34414555)

  • 1. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
    Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
    Wasiq M; K R; Gn A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-associated mucormycosis in India: Why such an outbreak?
    Pasquier G
    J Mycol Med; 2023 Aug; 33(3):101393. PubMed ID: 37182234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
    Singh AK; Singh R; Joshi SR; Misra A
    Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
    Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
    Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal analysis of the COVID-19-associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors.
    Chowdhary A; Gupta N; Wurster S; Kumar R; Mohabir JT; Tatavarthy S; Mittal V; Rani P; Barman P; Sachdeva N; Singh A; Sharma B; Jiang Y; Cuomo CA; Kontoyiannis DP
    Mycoses; 2023 Jun; 66(6):515-526. PubMed ID: 36790120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
    Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
    Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.
    Sahu M; Shah M; Mallela VR; Kola VR; Boorugu HK; Punjani AAR; Kumar RV; Kumar S; Manusrut M; Kumar SCR; Rathod R; Babu DM; Gonuguntla HK; Yedlapati GK; Mallu GR; Reddy YS; Reddy VV; Alwala S; Bongu VK; Kamalesh A; Kumar RNK; Jaishetwar GS; Bagapally RS; Srinivas JS; Balasubramaniam A; Rajagopalan BK; Pullikanti B; Prakasham SP; Nimmala P; Nagaraju B; Sahoo PR;
    Infection; 2023 Apr; 51(2):407-416. PubMed ID: 35922704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus Disease-19-associated Mucormycosis: A Single-center Observational Study of 69 Patients.
    Yadav DS; Chavan SA; Karnik ND; Kumar CA; Padhiyar RN; D'Souza D
    J Assoc Physicians India; 2024 Oct; 72(10):24-31. PubMed ID: 39390855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India.
    Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D
    J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucormycosis in the COVID-19 Environment: A Multifaceted Complication.
    Sharma R; Kumar P; Rauf A; Chaudhary A; Prajapati PK; Emran TB; Gonçalves Lima CM; Conte-Junior CA
    Front Cell Infect Microbiol; 2022; 12():937481. PubMed ID: 35923801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.
    Rudramurthy SM; Hoenigl M; Meis JF; Cornely OA; Muthu V; Gangneux JP; Perfect J; Chakrabarti A;
    Mycoses; 2021 Sep; 64(9):1028-1037. PubMed ID: 34133816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Past, Present and Future of COVID-19 Associated Mucormycosis: A Rapid Review.
    Sarfraz Z; Sarfraz A; Jaiswal V; Poudel S; Bano S; Hanif M; Singh Shrestha P; Sarfraz M; Michel G; Cherrez-Ojeda I
    J Prim Care Community Health; 2022; 13():21501319221099476. PubMed ID: 35587142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.
    Gambhir RS; Aggarwal A; Bhardwaj A; Kaur A; Sohi RK; Mehta S
    Rocz Panstw Zakl Hig; 2021; 72(3):239-244. PubMed ID: 34553877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
    Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B
    Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.